DK0621037T3 - Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK0621037T3
DK0621037T3 DK94105958T DK94105958T DK0621037T3 DK 0621037 T3 DK0621037 T3 DK 0621037T3 DK 94105958 T DK94105958 T DK 94105958T DK 94105958 T DK94105958 T DK 94105958T DK 0621037 T3 DK0621037 T3 DK 0621037T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
pyridopyrimidinedions
preparation
methods
compound
Prior art date
Application number
DK94105958T
Other languages
English (en)
Inventor
Harald Dr Furrer
Dirk Dr Seiffge
Ismahan Dr Okyayuz-Baklouti
John Joseph Dr Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0621037T3 publication Critical patent/DK0621037T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94105958T 1993-04-23 1994-04-18 Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler DK0621037T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313317 1993-04-23

Publications (1)

Publication Number Publication Date
DK0621037T3 true DK0621037T3 (da) 2000-01-17

Family

ID=6486199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94105958T DK0621037T3 (da) 1993-04-23 1994-04-18 Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler

Country Status (8)

Country Link
US (1) US5556854A (da)
EP (1) EP0621037B1 (da)
JP (1) JP3483160B2 (da)
AT (1) ATE181832T1 (da)
DE (1) DE59408453D1 (da)
DK (1) DK0621037T3 (da)
ES (1) ES2134284T3 (da)
GR (1) GR3031267T3 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
RU2203887C2 (ru) 1998-02-27 2003-05-10 Санкио Компани, Лимитед Циклические аминопроизводные, фармацевтическая композиция и способ профилактики заболевания
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
PA8539401A1 (es) * 2001-02-14 2002-10-28 Warner Lambert Co Quinazolinas como inhibidores de mmp-13
US6825180B2 (en) 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
US7208498B2 (en) * 2002-07-15 2007-04-24 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2013115884A2 (en) * 2011-11-15 2013-08-08 Trustees Of Boston University Pyridopyrimidinone inhibitors of viruses
WO2018031990A1 (en) * 2016-08-12 2018-02-15 Nanjing Gator Meditech Company, Ltd. Protein kinase regulators
CA3131740A1 (en) 2019-02-27 2020-09-03 Madera Therapeutics, LLC Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
US20230339947A1 (en) * 2019-02-27 2023-10-26 Madera Therapeutics, LLC Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
CN119039287A (zh) * 2023-05-29 2024-11-29 中国药科大学 一类四氢吡啶并嘧啶酮衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA762455A (en) * 1962-03-22 1967-07-04 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Pyrido-pyrimidines

Also Published As

Publication number Publication date
GR3031267T3 (en) 1999-12-31
EP0621037A1 (de) 1994-10-26
EP0621037B1 (de) 1999-07-07
DE59408453D1 (de) 1999-08-12
JP3483160B2 (ja) 2004-01-06
ES2134284T3 (es) 1999-10-01
ATE181832T1 (de) 1999-07-15
JPH06321944A (ja) 1994-11-22
US5556854A (en) 1996-09-17

Similar Documents

Publication Publication Date Title
NO931056L (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
DK0625505T3 (da) 2- Cyano-1,3-dion-derivater samt deres anvendelse som herbicider
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
BR0109703A (pt) Derivados de piperazina
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
DK0625508T3 (da) Svovlholdige derivater af 2-cyano-1,3-dioner samt deres anvendelse som herbicider
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
DK0621037T3 (da) Pyridopyrimidindioner, fremgangsmåder til deres fremstilling samt deres anvendelse som lægemidler
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
NO922934L (no) Cykloheksan- og tetrahydropyranderivater
AU670491B2 (en) Pharmaceutical for the treatment of skin disorders
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
NO933521D0 (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
NO882113D0 (no) Substituerte vinylcefalosporiner, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel.
NO944722L (no) 3-(fenylalkylaminoalkyloksy)-5-fenylpyrazol-forbindelser samt fremgangsmåter og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene
FI890173L (fi) Isoxazoler med nootropisk verkan.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
DK475989D0 (da) Anvendelse af pyrazolopyridinderivater eller fysiologisk acceptable salte deraf i laegmidler til behandling af epilepsi
FI941850A0 (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
ES2068040T3 (es) Sales de 3-(cis-2,6-dimetilpiperidino)-sidnonimina.
NO924472D0 (no) Nikotinylalanin som terapeutisk middel med virkning paa sentralnervesystemet